SRTA

Strata Critical Medical Stock Analysis

AI Rating

Good
  • Quality3/10
  • Growth 9/10
  • Value 5/10
Strata Critical Medical sales and earnings growth
SRTA Growth
Great
  • Revenue Y/Y 32.10%
  • EPS Y/Y 264.71%
  • FCF Y/Y -161.67%
Strata Critical Medical gross and profit margin trends
SRTA Profitability
Good
  • Gross margin 21.70%
  • EPS margin 18.50%
  • ROIC 5Y -8.76%
Strata Critical Medical net debt vs free cash flow
SRTA Risk
Great
  • Debt / Equity 0.0
  • Debt / FCF 0.0
  • Interest coverage NA

Strata Critical Medical stock volatility is higher than the overall market. We give it a Great risk rating.

↗ More Airports & Air Services stocks